Correlation Between Hironic and Pharmicell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hironic and Pharmicell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hironic and Pharmicell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hironic Co and Pharmicell, you can compare the effects of market volatilities on Hironic and Pharmicell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hironic with a short position of Pharmicell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hironic and Pharmicell.

Diversification Opportunities for Hironic and Pharmicell

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Hironic and Pharmicell is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Hironic Co and Pharmicell in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmicell and Hironic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hironic Co are associated (or correlated) with Pharmicell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmicell has no effect on the direction of Hironic i.e., Hironic and Pharmicell go up and down completely randomly.

Pair Corralation between Hironic and Pharmicell

Assuming the 90 days trading horizon Hironic is expected to generate 1.35 times less return on investment than Pharmicell. But when comparing it to its historical volatility, Hironic Co is 1.86 times less risky than Pharmicell. It trades about 0.22 of its potential returns per unit of risk. Pharmicell is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  828,000  in Pharmicell on October 28, 2024 and sell it today you would earn a total of  89,000  from holding Pharmicell or generate 10.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Hironic Co  vs.  Pharmicell

 Performance 
       Timeline  
Hironic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hironic Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Hironic is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Pharmicell 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmicell are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Pharmicell sustained solid returns over the last few months and may actually be approaching a breakup point.

Hironic and Pharmicell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hironic and Pharmicell

The main advantage of trading using opposite Hironic and Pharmicell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hironic position performs unexpectedly, Pharmicell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmicell will offset losses from the drop in Pharmicell's long position.
The idea behind Hironic Co and Pharmicell pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments